• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴雷特食管高级别异型增生的外科治疗

Surgical management of high-grade dysplasia in Barrett's esophagus.

作者信息

Rice T W, Falk G W, Achkar E, Petras R E

机构信息

Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic Foundation, Ohio.

出版信息

Am J Gastroenterol. 1993 Nov;88(11):1832-6.

PMID:8237928
Abstract

The role of surgery in patients with Barrett's esophagus and high-grade dysplasia is controversial. The aims of this study were to determine the prevalence of unsuspected early cancer and to evaluate surgical outcome in a cohort of patients with high-grade dysplasia. Records of all 16 patients who underwent esophagectomy for high-grade dysplasia from 1986 to 1991 were reviewed. All had preoperative endoscopy with no gross evidence of carcinoma, and none had a preoperative diagnosis of intramucosal or invasive carcinoma. Intramucosal carcinoma was found in six (38%) resection specimens. There were no cases of invasive carcinoma or lymph node metastases. One patient (6%) died 3 months postoperatively. The remaining patients are alive without evidence of recurrent cancer (range of follow-up, 2-68 months). Early postoperative complications occurred in seven patients (44%). Late complications occurred in 11 patients (73%). Anastomotic strictures accounted for seven of the 11 (64%) late complications. Complications were successfully managed conservatively in all but two patients. One required laryngectomy for chronic aspiration and another required a gastrojejunostomy for gastric outlet obstruction. Intramucosal carcinoma that had been unsuspected is frequently found in patients with Barrett's esophagus and high-grade dysplasia. Mortality associated with esophagectomy is low, and perioperative complications can usually be managed conservatively. Esophageal resection is indicated in appropriately selected patients with Barrett's esophagus and high-grade dysplasia.

摘要

手术在巴雷特食管和高级别异型增生患者中的作用存在争议。本研究的目的是确定未被怀疑的早期癌症的患病率,并评估一组高级别异型增生患者的手术结果。回顾了1986年至1991年期间因高级别异型增生接受食管切除术的所有16例患者的记录。所有患者术前内镜检查均未发现明显癌证据,且术前均未诊断为黏膜内癌或浸润性癌。在6例(38%)切除标本中发现了黏膜内癌。没有浸润性癌或淋巴结转移病例。1例患者(6%)术后3个月死亡。其余患者存活,无癌症复发迹象(随访时间为2 - 68个月)。7例患者(44%)发生了早期术后并发症。11例患者(73%)发生了晚期并发症。11例晚期并发症中有7例(64%)是吻合口狭窄。除2例患者外,所有并发症均通过保守治疗成功处理。1例因慢性误吸需要行喉切除术,另1例因胃出口梗阻需要行胃空肠吻合术。在巴雷特食管和高级别异型增生患者中经常发现未被怀疑的黏膜内癌。食管切除术相关的死亡率较低,围手术期并发症通常可以通过保守治疗处理。对于适当选择的巴雷特食管和高级别异型增生患者,建议行食管切除术。

相似文献

1
Surgical management of high-grade dysplasia in Barrett's esophagus.巴雷特食管高级别异型增生的外科治疗
Am J Gastroenterol. 1993 Nov;88(11):1832-6.
2
Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.完全性巴雷特食管根除性内镜黏膜切除术:治疗高级别异型增生和黏膜内癌的有效治疗方式——一项美国单中心经验
Am J Gastroenterol. 2009 Nov;104(11):2684-92. doi: 10.1038/ajg.2009.465. Epub 2009 Aug 18.
3
Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.一个地区退伍军人管理局巴雷特食管队列中的发育异常及进一步肿瘤进展风险
Am J Gastroenterol. 2005 Apr;100(4):775-83. doi: 10.1111/j.1572-0241.2005.41300.x.
4
Treatment of Barrett's esophagus with high-grade dysplasia.巴雷特食管伴高级别异型增生的治疗。
Expert Rev Anticancer Ther. 2009 Mar;9(3):303-16. doi: 10.1586/14737140.9.3.303.
5
Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study.巴雷特食管、高级别异型增生及早期腺癌:一项病理学研究
Am J Gastroenterol. 1997 Apr;92(4):586-91.
6
Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett's esophagus: a 20-year experience.巴雷特食管高级别异型增生或黏膜内腺癌食管切除术中黏膜下浸润癌的低发生率:20年经验
Gastrointest Endosc. 2009 Apr;69(4):777-83. doi: 10.1016/j.gie.2008.05.013. Epub 2009 Jan 10.
7
Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.短节段巴雷特食管的发育异常:一项为期3年的前瞻性随访研究
Am J Gastroenterol. 1997 Nov;92(11):2012-6.
8
The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression.巴雷特食管低度发育异常的诊断及其对疾病进展的影响。
Am J Gastroenterol. 2000 Dec;95(12):3383-7. doi: 10.1111/j.1572-0241.2000.03348.x.
9
Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.巴雷特食管合并高级别异型增生或黏膜内癌患者初次内镜黏膜切除术标本中鳞状上皮下的高级病理学表现:对监测和内镜治疗管理的意义
Gastrointest Endosc. 2009 Sep;70(3):417-21. doi: 10.1016/j.gie.2009.01.047. Epub 2009 Jun 24.
10
Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.内镜黏膜切除术实现完全巴雷特食管消除(CBE-EMR)治疗高级别异型增生和黏膜内癌的长期随访
Endoscopy. 2007 Dec;39(12):1086-91. doi: 10.1055/s-2007-966788. Epub 2007 Aug 15.

引用本文的文献

1
Comparison of two multiband mucosectomy devices for endoscopic resection of Barrett's esophagus-related neoplasia.两种多波段黏膜切除术装置用于 Barrett 食管相关肿瘤内镜切除的比较。
Surg Endosc. 2019 Nov;33(11):3665-3672. doi: 10.1007/s00464-018-06655-0. Epub 2019 Jan 22.
2
EMR is not inferior to ESD for early Barrett's and EGJ neoplasia: An extensive review on outcome, recurrence and complication rates.对于早期巴雷特食管和食管胃交界部肿瘤,内镜黏膜切除术(EMR)并不逊色于内镜黏膜下剥离术(ESD):关于结局、复发率和并发症发生率的广泛综述
Endosc Int Open. 2014 Jun;2(2):E58-64. doi: 10.1055/s-0034-1365528. Epub 2014 May 7.
3
Barrett's Esophagus.
巴雷特食管
Curr Treat Options Gastroenterol. 2014 Jun;12(2):169-82. doi: 10.1007/s11938-014-0012-0.
4
Management controversies in Barrett's oesophagus.巴雷特食管的管理争议。
J Gastroenterol. 2014 Feb;49(2):195-205. doi: 10.1007/s00535-013-0816-z. Epub 2013 Jun 5.
5
Expert pathology review and endoscopic mucosal resection alters the diagnosis of patients referred to undergo therapy for Barrett's esophagus.专家病理审查和内镜黏膜切除术改变了接受 Barrett 食管治疗的患者的诊断。
Surg Endosc. 2013 Aug;27(8):2836-40. doi: 10.1007/s00464-013-2830-x. Epub 2013 Feb 7.
6
Prospective feasibility study on the use of multiband mucosectomy for endoscopic resection of early squamous neoplasia in the esophagus.多波段黏膜切除术在食管早期鳞状上皮内瘤变内镜切除中应用的前瞻性可行性研究。
Endoscopy. 2013;45(3):167-73. doi: 10.1055/s-0032-1326011. Epub 2012 Dec 20.
7
Management of Barrett's oesophagus and intramucosal oesophageal cancer: a review of recent development.巴雷特食管和食管黏膜内癌的处理:近期进展综述。
Therap Adv Gastroenterol. 2012 Sep;5(5):285-99. doi: 10.1177/1756283X12446668.
8
Barrett's Esophagus: A Review of Biology and Therapeutic Approaches.巴雷特食管:生物学与治疗方法综述
Gastrointest Cancer Res. 2012 Mar;5(2):49-57.
9
The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review.巴雷特食管高级别异型增生或黏膜内癌患者的淋巴结转移风险:系统评价。
Am J Gastroenterol. 2012 Jun;107(6):850-62; quiz 863. doi: 10.1038/ajg.2012.78.
10
Pre-clinical evaluation of fluorescent deoxyglucose as a topical contrast agent for the detection of Barrett's-associated neoplasia during confocal imaging.荧光脱氧葡萄糖作为共聚焦成像中检测 Barrett 相关肿瘤的局部对比剂的临床前评估。
Technol Cancer Res Treat. 2011 Oct;10(5):431-41. doi: 10.7785/tcrt.2012.500220.